Vicore Pharma Holding AB (publ) (VICO) — Capital Reinvestment Ratio

Latest as of September 2018: 7.73x

Vicore Pharma Holding AB (publ) (VICO) has a Capital Reinvestment Ratio of 7.73x as of September 2018, meaning it reinvests 8% of its operating cash flow (Skr700.00K) in capital expenditures (Skr5.41 Million). Check Vicore Pharma Holding AB (publ) tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

7.73x

Capex / Operating Cash Flow

Operating Cash Flow

Skr700.00K

SEK

Capital Expenditures

Skr5.41 Million

SEK

Data as of

Sep 2018

Most recent filing

Annual Capital Reinvestment Ratio for Vicore Pharma Holding AB (publ) (None–None)

Year-by-year Capital Reinvestment Ratio for Vicore Pharma Holding AB (publ) from None to None. See cash generation quality of Vicore Pharma Holding AB (publ) to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow